HIV and Other Infectious Consequences of Substance Abuse

$221,992T32FY2015DANIH

Miriam Hospital, Providence RI

Investigators

Linked publications & trials

Paper 39699824 Paper 39290079 Paper 39177671 Paper 39029371 Paper 38896468 Paper 38633813 Paper 38617402 Paper 38536139 Paper 38497959 Paper 38158724 Paper 38152551 Paper 37365862 Paper 37113046 Paper 36891978 Paper 36723769 Paper 36633764 Paper 36595198 Paper 36418138 Paper 36402082 Paper 35973341 Paper 35951448 Paper 35895179 Paper 35895058 Paper 35862886 Paper 35663245 Paper 35486953 Paper 35468556 Paper 35068616 Paper 34954747 Paper 34915910 Paper 34817717 Paper 34812962 Paper 34785420 Paper 34660886 Paper 34542090 Paper 34236297 Paper 34013442 Paper 33825640 Paper 33622466 Paper 33534692 Paper 33427073 Paper 33218751 Paper 33138924 Paper 33138623 Paper 33028467 Paper 32807624 Paper 32631187 Paper 32604133 Paper 32600619 Paper 32530889 Paper 32496865 Paper 32415422 Paper 32324483 Paper 32296819 Paper 32226962 Paper 32143185 Paper 32134500 Paper 32050112 Paper 32014870 Paper 32006154 Paper 31884571 Paper 31634378 Paper 31633611 Paper 31633456 Paper 31622366 Paper 31537431 Paper 31509529 Paper 31489089 Paper 31456201 Paper 31444712 Paper 31341344 Paper 31287625 Paper 31100636 Paper 31079476 Paper 30915581 Paper 30898799 Paper 30876402 Paper 30760091 Paper 30709076 Paper 30652205 Paper 30570528 Paper 30481074 Paper 30413504 Paper 30393017 Paper 30286737 Paper 30278602 Paper 30268101 Paper 30243145 Paper 30218319 Paper 30165569 Paper 30142141 Paper 30104118 Paper 30095563 Paper 29970355 Paper 29968140 Paper 29869581 Paper 29847478 Paper 29807234 Paper 29725192 Paper 29615383

Abstract

DESCRIPTION (provided by applicant): This is the second competitive re-application for T32DA013911 entitled HIV and Other Infectious Consequences of Substance Abuse and seeks funding for Years 11-15. One of the most important strengths of this program is that its development has risen from a trans- disciplinary collaboration between substance abuse treatment, HIV medicine and other infectious diseases (Hepatitis B/C, STDs, and TB), behavioral sciences, and epidemiology and biostatistics. The collaboration between these diverse disciplines was in answer to the challenges faced from the HIV epidemic at The Miriam Hospital Immunology Center. Approximately 60% of the patients at The Immunology Center struggle with substance abuse in one or more of its many forms (alcohol abuse, cocaine or opiate addiction, and poly-substance abuse). This collaboration brings together core expertise from the Division of Infectious Diseases, the Lifespan/Tufts/Brown Center for AIDS Research, the Brown Center for Alcohol and Addiction Studies, The Centers for Behavioral and Preventive Medicine, and Brown University Center for Statistical Studies. Relying on expertise from one discipline to address clinical research is not an adequate model and the trans-disciplinary approach greatly enhances diagnosis, prevention and treatment research of HIV and other infectious diseases among active substance abusers and within communities that are heavily impacted by substance abuse.

View original record on NIH RePORTER →